KDNY - Chinook Therapeutics GAAP EPS of -$0.61 in-line revenue of $0.42M in-line August, 08 2022 05:26 PM Chinook Therapeutics Inc Com Chinook Therapeutics press release ( NASDAQ: KDNY ): Q2 GAAP EPS of -$0.61 in-line. Revenue of $0.42M (+1300.0% Y/Y) in-line. For further details see: Chinook Therapeutics GAAP EPS of -$0.61 in-line, revenue of $0.42M in-line